Your browser doesn't support javascript.
loading
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
Garsen, Marjolein; Buijsers, Baranca; Sol, Marloes; Gockeln, Lena; Sonneveld, Ramon; van Kuppevelt, Toin H; de Graaf, Mark; van den Born, Jacob; Kamps, Jan A A M; van Raalte, Daniël H; van der Meer, Rutger W; Lamb, Hildo J; Hillebrands, Jan-Luuk; Rabelink, Ton J; Maciej-Hulme, Marissa L; Krenning, Guido; Nijenhuis, Tom; van der Vlag, Johan.
Afiliación
  • Garsen M; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Buijsers B; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Sol M; Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
  • Gockeln L; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Sonneveld R; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Kuppevelt TH; Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • de Graaf M; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van den Born J; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands.
  • Kamps JAAM; Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
  • van Raalte DH; Diabetes Center, VU University Medical Center, Amsterdam, the Netherlands.
  • van der Meer RW; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Lamb HJ; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Hillebrands JL; Division of Pathology, University Medical Center Groningen, Groningen, the Netherlands.
  • Rabelink TJ; Department of Nephrology and Einthoven Laboratory for Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Maciej-Hulme ML; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Krenning G; Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
  • Nijenhuis T; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van der Vlag J; Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Johan.vanderVlag@radboudumc.nl.
EBioMedicine ; 90: 104506, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36889064
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Enfermedades Renales Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Enfermedades Renales Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos